GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Claritas Pharmaceuticals Inc (FRA:S6VA) » Definitions » Book Value per Share

Claritas Pharmaceuticals (FRA:S6VA) Book Value per Share : €0.08 (As of Sep. 2021)


View and export this data going back to 2007. Start your Free Trial

What is Claritas Pharmaceuticals Book Value per Share?

Claritas Pharmaceuticals's book value per share for the quarter that ended in Sep. 2021 was €0.08.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Claritas Pharmaceuticals's current price is €0.005. Its book value per share for the quarter that ended in Sep. 2021 was €0.08. Hence, today's PB Ratio of Claritas Pharmaceuticals is 0.06.


Claritas Pharmaceuticals Book Value per Share Historical Data

The historical data trend for Claritas Pharmaceuticals's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Claritas Pharmaceuticals Book Value per Share Chart

Claritas Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.62 -1.51 0.64 -0.12 0.04

Claritas Pharmaceuticals Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.04 0.01 0.07 0.08

Competitive Comparison of Claritas Pharmaceuticals's Book Value per Share

For the Biotechnology subindustry, Claritas Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Claritas Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Claritas Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Claritas Pharmaceuticals's PB Ratio falls into.



Claritas Pharmaceuticals Book Value per Share Calculation

Claritas Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Dec. 2020 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.24-0.00)/28.55
=0.04

Claritas Pharmaceuticals's Book Value Per Share for the quarter that ended in Sep. 2021 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2.79-0.00)/35.41
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Claritas Pharmaceuticals  (FRA:S6VA) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Claritas Pharmaceuticals Book Value per Share Related Terms

Thank you for viewing the detailed overview of Claritas Pharmaceuticals's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Claritas Pharmaceuticals (FRA:S6VA) Business Description

Traded in Other Exchanges
N/A
Address
4040 Civic Center Drive, Suite 200, San Rafael, CA, USA, 94903
Claritas Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company developing a portfolio of pharmaceutical products in Canada. It develops new treatments for a variety of diseases and disorders, by discovering, developing, manufacturing, and delivering human therapeutics.

Claritas Pharmaceuticals (FRA:S6VA) Headlines

No Headlines